- Home
- EDIT vs MVO Comparison
EDIT vs MVO Comparison
Compare EDIT & MVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- MVO
- Stock Information
- Founded
- EDIT 2013
- MVO 2006
- Country
- EDIT United States
- MVO United States
- Employees
- EDIT N/A
- MVO N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- MVO Oil & Gas Production
- Sector
- EDIT Health Care
- MVO Energy
- Exchange
- EDIT Nasdaq
- MVO Nasdaq
- Market Cap
- EDIT 108.1M
- MVO 95.7M
- IPO Year
- EDIT 2016
- MVO N/A
- Fundamental
- Price
- EDIT $1.92
- MVO $5.33
- Analyst Decision
- EDIT Buy
- MVO
- Analyst Count
- EDIT 14
- MVO 0
- Target Price
- EDIT $8.08
- MVO N/A
- AVG Volume (30 Days)
- EDIT 5.8M
- MVO 55.1K
- Earning Date
- EDIT 03-03-2025
- MVO 01-01-0001
- Dividend Yield
- EDIT N/A
- MVO 17.46%
- EPS Growth
- EDIT N/A
- MVO N/A
- EPS
- EDIT N/A
- MVO 1.46
- Revenue
- EDIT $61,759,000.00
- MVO N/A
- Revenue This Year
- EDIT N/A
- MVO N/A
- Revenue Next Year
- EDIT N/A
- MVO N/A
- P/E Ratio
- EDIT N/A
- MVO $7.29
- Revenue Growth
- EDIT 150.95
- MVO N/A
- 52 Week Low
- EDIT $1.12
- MVO $8.85
- 52 Week High
- EDIT $11.58
- MVO $13.95
- Technical
- Relative Strength Index (RSI)
- EDIT 55.72
- MVO 30.14
- Support Level
- EDIT $1.12
- MVO $5.36
- Resistance Level
- EDIT $3.30
- MVO $5.62
- Average True Range (ATR)
- EDIT 0.30
- MVO 0.23
- MACD
- EDIT 0.12
- MVO 0.10
- Stochastic Oscillator
- EDIT 36.70
- MVO 59.72
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About MVO MV Oil Trust Units of Beneficial Interests
MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These oil and gas properties include producing oil and gas wells.